Targeting AGTR1/NF- κB/CXCR4 axis by miR-155 attenuates oncogenesis in glioblastoma.

This study opens new avenues for using IKK inhibitors and miRNA-155 replacement therapies for the treatment of AGTR1-positive malignancies.
PMID: 32896760 [PubMed - as supplied by publisher]

Source: Neoplasia - September 3, 2020 Category: Cancer & Oncology Authors: Singh A, Srivastava N, Yadav A, Ateeq B Tags: Neoplasia Source Type: research